Lecture 1 Management of Cervical Cancer

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 17

MANAGEMENT OF

CERVICAL CANCER:
INTRODUCTION, EPIDEMIOLOGY
AND CLINICAL FEATURES

Dr. Habshoh Hat


Dr. Fuziah Paimin
Family Medicine Specialist
Training of Core Trainer Clinical Practice Guideline
Management of Cervical Cancer (Second Edition)
INTRODUCTION
Important health issue among women in
Malaysia.
Available screening programs for early
detection of pre-invasive diseases.
However, many women were still diagnosed
at invasive stage of cervical cancer
Tremendous implications to the patients,
caregivers & healthcare system
Cervical Cancer (CC):
Increasing trend :
2008 2012
New cancer case: 12.7 million 14.1 million
Cancer death : 7.6 million 8.2 million
Ref: Torre LA, Bray F, Siegel RL, et al. Global Cancer Statistics, 2012. 2015;00(00):1–22
Worldwide:

5 th after lung, breast, colorectal


& prostate ca.

70% of 4th after breast,


CC occur colorectal and lung
in low cancer.
resourced
countries

Ref: Torre LA, Bray F, Siegel RL, et al. Global Cancer Statistics, 2012. 2015;00(00):1-22
Worldwide:
5th after lung, breast, colorectal &
prostate ca

70% of CC
occur 4th after breast,
in low colorectal and lung
resourced cancer.
countries
2nd
after
Breast
Ca.

ASR is
Rate of CC highest among
1. Indian
increases after 30 (10.3/100,000)
2.Chinese
year old and peaked at (9.5/100,000)
3. Malay
65-69 year old (5.3/100,000))
ASR: age-standardised rate
Ref: NCR 2007
WHO IS HIGH RISK?
• Primary cause of cervical cancer is HPV
(human Papilloma Virus) which is transmitted sexually.

• Risk factors associated with cervical cancer are:


1. > 3 sexual partners
2. Early sexualy intercourse (< 17 yearold)
3. First delivery before 17 year old
4. > 10 years of oral contraceptive
5. High parity (≥ 7 full term pregnancies)
6. Smoking
7. Low socioeconomic status
CLINICAL FEATURES

Among those with PCB:


Conventional Pap smear: Colposcopy:
Sensitivity : 50% Sensitivity : 78.6%
Specificity : 86.5% Specificity :-
Positive predictive value: Positive predictive value:
92.8% 23.4%

PCB: post coital bleeding


Ref: Tehranian A et al. Evaluation of women presenting with postcoital bleeding by cytology and colposcopy. Int J
Gynaecology Obstet; 2009;105(1):18-20
Common presenting symptoms in CC are:
postmenopausal bleeding (84.0%)
vaginal discharge (72.0%)
PCB (64.0%) and
abdominal pain (56.0%)1

Prevalence of PCB in cervical cancer ranges


between 0.7% to 39%2
Ref:
1. Ikechebelu JI et al. Clinicopathological analysis of cervical cancer seen in a tertiary health facility in Nnewi,
south-east Nigeria. J Obstet Gynaecol. 2010;30(3):299–301
2. Shapley M et al. A systematic review of postcoital bleeding and risk of cervical cancer. Br J Gen Pract.
2006;56(527):453–60
STAGE OF DISEASE AT PRESENTATION

35
34.7
30

25 25.6

20 21
18.7
15

10

0
STAGE 1 STAGE 2 STAGE 3 STAGE 4

Ref: Malaysian National Cancer Statistic 2007


Referral

• Appropriate referral can improve the quality


of care to the patient

• Referral to gynaecologist/gynae-oncologist
clinic after abnormal cytology or symptoms
is important to establish prompt diagnosis
Time frame for Referral of abnormal
cytology to gynaecology clinic
Referral

Ref:
Sahu B etal. Prevalence of pathology in women attending colposcopy for post coital bleeding
with negative cytology. Arch Gynecol Obstet. 2007;276(5):471–3.
Algorithm 1:
Assessment
of Cervical
Cancer
Take Home Messages
1. Most cervical cancer patients are asymptomatic &
presented at late stage of disease, hence pap smear
screening is of utmost importance in early detection.
2. The common symptoms are postmenopausal bleeding,
vaginal discharge, post coital bleeding and abdominal
pain.
3. Appropriate and timely referral is important to establish
prompt diagnosis and management
Thank You

You might also like